On September 24, 2024, Granules India Ltd, a major pharmaceutical company from Hyderabad, launched its Mobile Cancer Screening Unit at AIG Hospitals.
This initiative, led by the Granules Trust in collaboration with the Asian Medical Foundation, UC Breast Foundation, and AIG Hospitals, aims to improve cancer detection and treatment in underprivileged communities.
The new mobile unit, named “Breast Health Express,” is equipped with advanced medical technology. It features mammography and ultrasound equipment, along with facilities for important health checks like haemoglobin, blood pressure, and glucose levels. This mobile clinic represents a significant step forward in providing fair and accessible healthcare. By offering these essential services and distributing free medicines, the initiative aims to transform cancer screening, especially focusing on early detection of breast cancer.
Mrs Uma Chigurupati, Executive Director of Granules India Ltd and Chairperson of the Granules Trust, emphasised the company’s long-term vision for community well-being, “The launch of the Breast Health Express embodies Granules India’s core philosophy of innovating beyond pharmaceuticals to make a direct impact on public health.”
He further added, “This launch is a testament to our commitment to addressing critical healthcare gaps, particularly in rural areas where access is often limited. By bringing breast cancer screening services to underserved populations, we are not only addressing an urgent health need but also reaffirming our belief that healthcare should be accessible to all.”
The Breast Health Express is launching in October to align with Breast Cancer Awareness Month, highlighting the global effort to prevent and detect breast cancer early. The mobile unit will start its operations in and around Hyderabad, with plans to expand to more districts in Telangana in the coming months.
Granules India Limited was founded in 1991 and is a rapidly growing Indian pharmaceutical company based in Hyderabad. The company is known for its excellent facilities and dedication to quality, operational efficiency, and customer service. Granules is one of the few pharmaceutical companies globally involved in every part of the manufacturing process, from Active Pharmaceutical Ingredients (APIs) to Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages (FDs). Its products are supplied to over 300 customers in both regulated and semi-regulated markets, reaching more than 80 countries worldwide, with offices in India, the US, and the UK.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
